Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen receptors (ER) and progesterone receptors (PR) or overexpressed human epidermal growth factor receptor 2 (HER2) [2]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.